Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AB103

Known as: AB103 peptide, SPMLVAYD, p2TA peptide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Background: The necessity of mesh fixation in laparoscopic totally extraperitoneal (TEP) inguinal hernia repair remains… Expand
2015
2015
Non-obstructive azoospermia (NOA), a severe form of male infertility, is often suspected to be linked to currently undefined… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
2015
2015
BACKGROUND Severe gram-negative bacterial infections and sepsis are major causes of morbidity and mortality. Dysregulated… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
Objective Non-obstructive azoospermia (NOA), a severe form of male infertility, is often suspected to be linked to currently… Expand
Highly Cited
2014
Highly Cited
2014
IMPORTANCE Necrotizing soft-tissue infections (NSTI) have high morbidity and mortality rates despite aggressive surgical… Expand
2014
2014
The goal of this study was to elucidate the action of the CD28 mimetic peptide p2TA (AB103) that attenuates an excessive… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Thearticle byBulger et al1 represents an advance in theworld of surgical infections as the first interventional trial using an… Expand
2013
2013
Staphylococcus aureus and group A Streptococcus pyogenes (GAS) express superantigen (SAg) exotoxin proteins capable of inducing… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
AB103 is a novel CD28 antagonist peptide currently in clinical development that modulates CD28 signaling in T cells, without… Expand
  • table 2
  • figure 3
  • table 2
  • table 3
  • table 2
1990
1990
A model was formulated to examine specific experimental data of growth and heterologous product formation with recombinant… Expand